July 28, 2017

Precisis AG successfully increases capital

Precisis AG is investing in the clinical phase of its product development EASEE®. The medical technology company has increased its share capital to approximately 1.5 million Euros for this purpose. The increase in stock gives it a gross revenue of approximately 3.5 million Euros.